China Pharma Holdings (CPHI) Net Equity Issued and Repurchased (2021)
China Pharma Holdings' (CPHI) quarterly Net Equity Issued and Repurchased came in at $7.3 million in Q4 2021, up 438.26% on a QoQ basis from -$2.2 million in Q3 2021.
China Pharma Holdings (CPHI) Net Equity Issued and Repurchased (2021) Analysis & Trends
China Pharma Holdings (CPHI) has 1 years of Net Equity Issued and Repurchased data on file, last reported at $7.3 million in Q4 2021.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $7.3 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $5.0 million (changed N/A YoY) and the FY2021 annual result came in at $5.0 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased rose to $7.3 million in Q4 2021, from -$2.2 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $7.3 million in Q4 2021 to a low of -$2.2 million in Q3 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | China Pharma Holdings | 41.74 Mn | 41.44 Mn | 83,566.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 7.32 Mn |
| Dec 31, 2021 | 7.32 Mn |
| Sep 30, 2021 | -2.16 Mn |
| Sep 30, 2021 | -2.16 Mn |
| Jun 30, 2021 | -301.00 |
| Jun 30, 2021 | -301.00 |
| Mar 31, 2021 | -154,215.00 |
| Mar 31, 2021 | -154,215.00 |